Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Change in Receivables (2018 - 2026)

TransMedics has reported Change in Receivables over the past 8 years, most recently at $3.6 million for Q4 2025.

  • For Q4 2025, Change in Receivables fell 54.32% year-over-year to $3.6 million; the TTM value through Dec 2025 reached -$14.0 million, down 140.66%, while the annual FY2025 figure was -$14.0 million, 140.66% down from the prior year.
  • Change in Receivables for Q4 2025 was $3.6 million at TransMedics, up from -$24.1 million in the prior quarter.
  • Over five years, Change in Receivables peaked at $44.1 million in Q1 2025 and troughed at -$37.5 million in Q2 2025.
  • A 5-year average of $3.8 million and a median of $4.5 million in 2022 define the central range for Change in Receivables.
  • Biggest five-year swings in Change in Receivables: skyrocketed 895.54% in 2022 and later tumbled 4856.14% in 2025.
  • Year by year, Change in Receivables stood at $1.8 million in 2021, then surged by 197.85% to $5.4 million in 2022, then plummeted by 47.71% to $2.8 million in 2023, then skyrocketed by 178.15% to $7.8 million in 2024, then plummeted by 54.32% to $3.6 million in 2025.
  • Business Quant data shows Change in Receivables for TMDX at $3.6 million in Q4 2025, -$24.1 million in Q3 2025, and -$37.5 million in Q2 2025.